Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Several melatonin receptors agonists (ramelteon, prolonged-release melatonin, agomelatine and tasimelteon) have recently become available for the treatment of insomnia, depression and circadian rhythms sleep-wake disorders. The efficacy and safety profiles of these compounds in the treatment of the indicated disorders are reviewed. Accumulating evidence indicates that sleep-wake disorders and co-existing medical conditions are mutually exacerbating. This understanding has now been incorporated into the new Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Therefore, when evaluating the risk/benefit ratio of sleep drugs, it is pertinent to also evaluate their effects on wake and comorbid condition. Beneficial effects of melatonin receptor agonists on comorbid neurological, psychiatric, cardiovascular and metabolic symptomatology beyond sleep regulation are also described. The review underlines the beneficial value of enhancing physiological sleep in comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders: An Opportunity for Prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.1989.03430110069030 · Cited by 2,252
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Sleep and Alzheimer disease pathology--a bidirectional relationship
Ju, Y.-E. S., Lucey, B. P., & Holtzman, D. M. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.269 · Cited by 996 · cited 1×
“Compelling evidence indicates a causal link between poor sleep and increased AD risk and memory loss [88–90].”
BackgroundBuysse, D. J. (2013) · JAMA · doi:10.1001/jama.2013.193 · Cited by 965
Place of chronic insomnia in the course of depressive and anxiety disorders
Ohayon, M. M., & Roth, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00052-3 · Cited by 873 · cited 1×
“04 to 6 times greater in patients with severe insomnia as compared to those without insomnia and increasing insomnia severity is associated with increased chronic medical and psychiatric illnesses [49,50].”
BackgroundLim, A. S. P., Kowgier, M., Yu, L., Buchman, A. S., & Bennett, D. A. (2013) · Sleep · doi:10.5665/sleep.2802 · Cited by 793 · cited 1×
“Compelling evidence indicates a causal link between poor sleep and increased AD risk and memory loss [88–90].”
BackgroundSleep Quality and Preclinical Alzheimer Disease
Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., Morris, J. C., & Holtzman, D. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2334 · Cited by 744 · cited 2×
“A recent study on sleep quality and preclinical AD demonstrated that Aβ deposition in the preclinical stage of AD is associated with worse sleep quality but not with changes in sleep quantity [92].”
BackgroundRole of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735 · cited 1×
“subjects [8].”
Jansson-Fröjmark, M., & Lindblom, K. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.10.016 · Cited by 646 · cited 1×
“rhythm sleep disorders [45,46].”
Self-reported sleep and β-amyloid deposition in community-dwelling older adults
Spira, A. P., Gamaldo, A. A., An, Y., Wu, M. N., Simonsick, E. M., Bilgel, M., Zhou, Y., Wong, D. F., Ferrucci, L., & Resnick, S. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4258 · Cited by 570 · cited 1×
“Poor sleep quality or short sleep, increase β amyloid burden in brain areas typically affected in AD [91,92].”
BackgroundAbnormal melatonin synthesis in autism spectrum disorders
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002016 · Cited by 511 · cited 1×
“in children with autism spectrum disorder and some neurogenetic disorders have also been linked to insufficient or abnormal melatonin rhythms [12–15].”
BackgroundMelatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 1×
“in children with autism spectrum disorder and some neurogenetic disorders have also been linked to insufficient or abnormal melatonin rhythms [12–15].”
BackgroundAssociation of sleep-wake habits in older people with changes in output of circadian pacemaker
Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., Sánchez, R., Ríos, C. D., & Ronda, J. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)92817-y · Cited by 437
A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407
Melatonin, endocrine pancreas and diabetes
Peschke, E. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00519.x · Cited by 309
Liu, R.-Y., Zhou, J.-N., van Heerikhuize, J., Hofman, M. A., & Swaab, D. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5394 · Cited by 304 · cited 1×
“Melatonin levels both in CSF and in postmortem human pineal gland are already reduced in preclinical AD subjects, who are still cognitively intact and have only the earliest signs of AD neuropathology [113,114].”
BackgroundKoziróg, M., Poliwczak, A. R., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & Broncel, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00835.x · Cited by 299 · cited 1×
“In another open label study, melatonin administered for two months significantly improved lipid profile (decrease in LDL-C) and lowered blood pressure in 30 metabolic syndrome patients who did not respond to 3-month lifestyle modification in comparison with baseline, particularly in those with arterial hypertension [1…”
BackgroundCircadian rhythms of melatonin and cortisol in aging
Sharma, M., Palacios-Bois, J., Schwartz, G., Iskandar, H., Thakur, M., Quirion, R., & Nair, N. P. V. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90178-9 · Cited by 260 · cited 1×
“Endogenous melatonin levels decrease with age [10] and this decline”
BackgroundKnutson, K. L., Van Cauter, E., Zee, P., Liu, K., & Lauderdale, D. S. (2011) · Diabetes Care · doi:10.2337/dc10-1962 · Cited by 230
Diabetes and sleep: a complex cause-and-effect relationship
Barone, M. T. U., & Menna-Barreto, L. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.07.011 · Cited by 209 · cited 1×
“Several studies have suggested a direct association between diabetes and sleep disturbances [166–168].”
BackgroundMalik, S., Kanwar, A., Sim, L. A., Prokop, L. J., Wang, Z., Benkhadra, K., & Murad, M. H. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-18 · Cited by 206 · cited 1×
“Furthermore, patients with psychiatric diagnoses (including depression, post-traumatic stress disorder (PTSD), schizophrenia and comorbid sleep disturbances were significantly more likely to report suicidal behavior [54].”
BackgroundSleep disturbances and mood disorders: An epidemiologic perspective
Ford, D. E., & Cooper-Patrick, L. (2001) · Depression and Anxiety · doi:10.1002/da.1041 · Cited by 202 · cited 1×
“Insomnia has been confirmed as a risk factor for future mental illness [51] where individuals who report insomnia or poor quality of sleep may be at higher risk for relapse of depression throughout their lifetime [52,53].”
BackgroundEffects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men
Arangino, S., Cagnacci, A., Angiolucci, M., Vacca, A. M. B., Longu, G., Volpe, A., & Melis, G. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00112-5 · Cited by 200 · cited 1×
“Administration of melatonin (1 mg, acute, single blind, n = 17) significantly reduced blood pressure, the pulsatile index in the internal carotid artery and catecholamine levels in healthy men and young women 90 min after administration [158,159].”
BackgroundLanfranchi, P. A., Pennestri, M.-H., Fradette, L., Dumont, M., Morin, C. M., & Montplaisir, J. (2009) · Sleep · doi:10.1093/sleep/32.6.760 · Cited by 198 · cited 1×
“In particular, higher systolic BP and lower day-to-night systolic BP dipping were reported in normotensive insomniacs as compared with in normotensive good sleepers [135].”
ResultInsomnia and comorbid psychiatric disorders
Riemann, D. (2007) · Sleep Medicine · doi:10.1016/s1389-9457(08)70004-2 · Cited by 198 · cited 1×
“Evidences in the literature have demonstrated that 60%–80% of patients with major depression suffer from sleep changes, especially insomnia [47–49].”
BackgroundGangwisch, J. E., Malaspina, D., Posner, K., Babiss, L. A., Heymsfield, S. B., Turner, J. B., Zammit, G. K., & Pickering, T. G. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.202 · Cited by 168 · cited 1×
“subjects and depressed patients [136].”
Melatonin reduces night blood pressure in patients with nocturnal hypertension
Grossman, E., Laudon, M., Yalcin, R., Zengil, H., Peleg, E., Sharabi, Y., Kamari, Y., Shen-Orr, Z., & Zisapel, N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.002 · Cited by 168
Self-citationPossible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167 · cited 1×
“Nevertheless, the ability to remember previously learned items improved along with a significant reduction in depressed moods [121].”
BackgroundMelatonin improves sleep quality of patients with chronic schizophrenia
Shamir, E., Laudon, M., Barak, Y., Anis, Y., Rotenberg, V., Elizur, A., & Zisapel, N. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0509 · Cited by 139
Self-citationDisturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease
Bolitho, S. J., Naismith, S. L., Rajaratnam, S. M. W., Grunstein, R. R., Hodges, J. R., Terpening, Z., Rogers, N., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.10.016 · Cited by 139 · cited 1×
“There are also inconsistent findings with both enhanced and decreased melatonin secretion in PD patients [126,127].”
BackgroundMelatonin in Schizophrenic Outpatients With Insomnia: A Double-Blind, Placebo-Controlled Study
Kumar, P. N. S., Andrade, C., Bhakta, S. G., & Singh, N. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0208 · Cited by 102
Influences of melatonin administration on the circulation of women
Cagnacci, A., Arangino, S., Angiolucci, M., Maschio, E., & Melis, G. B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r335 · Cited by 100
DSM-5 Sleep-Wake Disorders Classification: Overview for Use in Clinical Practice
Reynolds, C. F., & O’Hara, R. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13010058 · Cited by 89 · cited 1×
“sleep disorders (comorbid insomnia) are interactive and bidirectional and it is not as important to make assumptions about what causes the sleep disorder [1].”
BackgroundGenetic variants in MTNR1B affecting insulin secretion
Müssig, K., Staiger, H., Machicao, F., Häring, H.-U., & Fritsche, A. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.502125 · Cited by 38 · cited 1×
“In several recent studies, a single nucleotide polymorphism of the human melatonin receptor 1B has been described as being causally linked to increased risk of developing type-2 diabetes [170–172].”
Background
Cited by
Melatonin as a Hormone: New Physiological and Clinical Insights
Cipolla-Neto, J., & Amaral, F. G. D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00084 · Cited by 635
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Endogenous non-enzymatic antioxidants in the human body
Mirończuk-Chodakowska, I., Witkowska, A. M., & Zujko, M. E. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.005 · Cited by 613
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
“5–2 h, with a metabolite with an even longer half-life (2–5 h) [25].”
Background
Metadata
- Authors
- Laudon, M., & Frydman-Marom, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-09-09
- Volume
- 15
- Issue
- 9
- Pages
- 15924-15950
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2158639142
- Cited by
- 149
- References
- 34
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.